NDC 60505-4779 – Pazopanib
Pazopanib 200 mg/1 · Tablet · Oral
Product NDC60505-4779
Product details
- Brand name
- Pazopanib
- Generic name
- Pazopanib
- Labeler
- Apotex Corp.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA217713
- Marketed since
- October 19, 2023
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Pazopanib 200 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 60505-4779-5 | 500 TABLET in 1 BOTTLE (60505-4779-5) | Oct 19, 2023 |
| 60505-4779-7 | 120 TABLET in 1 BOTTLE (60505-4779-7) | Oct 19, 2023 |
Other Pazopanib products
- 51407-872 Pazopanib 200 mg/1 · Tablet · Golden State Medical Supply, Inc.
- 59651-582 Pazopanib Hydrochloride 200 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 42291-939 Pazopanib Hydrochloride 200 mg/1 · Tablet, Film Coated · AvKARE
- 82293-022 Pazopanib Hydrochloride 200 mg/1 · Tablet, Film Coated · Novugen Pharma (USA) LLC.
- 63304-116 Pazopanib Hydrochloride 200 mg/1 · Tablet, Film Coated · SUN PHARMACEUTICAL INDUSTRIES, INC.
- 0480-4184 Pazopanib Hydrochloride 200 mg/1 · Tablet, Film Coated · Teva Pharmaceuticals, Inc.
- 13668-735 Pazopanib Hydrochloride 400 mg/1 · Tablet, Film Coated · Torrent Pharmaceuticals Limited